MATTHEW DEPAUL: Open Payments
NPI 1760761654 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 23 payments from 8 companies in 2025. Trend: 2023 $486 · 2024 $289 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| Abbott Laboratories | 7 | $154 |
| Genentech USA, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Saluda Medical Americas, Inc. | 2 | $30 |
| Averitas Pharma Inc. | 1 | $30 |
| SI-BONE, INC. | 1 | $24 |
| GENZYME CORPORATION | 1 | $22 |
Products named: PROCLAIM, BREZTRI, TEZSPIRE, Xolair, ZEPBOUND, Evoke, QUTENZA, DUPIXENT.
Industry payments across PA — which companies pay providers there.
